Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

GPR120 Agonist 3

🥰Excellent
Catalog No. T15413Cas No. 1599477-75-4
Alias GPR120-IN-1

GPR120 Agonist 3 (GPR120-IN-1) is a selective agonist of Gpr120 ( logEC50: -7.62).

GPR120 Agonist 3

GPR120 Agonist 3

🥰Excellent
Purity: 99.29%
Catalog No. T15413Alias GPR120-IN-1Cas No. 1599477-75-4
GPR120 Agonist 3 (GPR120-IN-1) is a selective agonist of Gpr120 ( logEC50: -7.62).
Pack SizePriceAvailabilityQuantity
1 mg$31In Stock
5 mg$81In Stock
10 mg$147In Stock
25 mg$289In Stock
50 mg$413In Stock
100 mg$619In Stock
200 mg$877In Stock
1 mL x 10 mM (in DMSO)$89In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "GPR120 Agonist 3"

Select Batch
Purity:99.29%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
GPR120 Agonist 3 (GPR120-IN-1) is a selective agonist of Gpr120 ( logEC50: -7.62).
Targets&IC50
GPR120:−7.62 (logEC50)
In vitro
GPR120-IN-1 causes a concentration-dependent response to recruiting β-arrestin-2 in both human and mouse Gpr120 expressing cells(EC50s: ~0.35 μM). GPR120-IN-1 produces concentration-dependent increases in IP3 production from both human and mouse Gpr120 expressing cells. GPR120-IN-1 strongly and comparably inhibits LPS-induced phosphorylation of Ikkβ, Tak1, and Jnk and blocked IκB degradation.
In vivo
GPR120-IN-1 treatment has beneficial effects on hepatic lipid metabolism. It causes decreased liver triglycerides, decreased hepatic steatosis, and DAGs, as well as decreased saturated free fatty acid content. GPR120-IN-1 causes improved insulin sensitivity with increased glucose infusion rates. It also enhanced the insulin stimulated-glucose disposal rate. Only in WT mice, along with a marked increase in the ability of insulin to suppress hepatic glucose production.
AliasGPR120-IN-1
Chemical Properties
Molecular Weight405.84
FormulaC19H23ClF3NO3
Cas No.1599477-75-4
SmilesOC(=O)CC1CCC2(CC1)CCN(CC2)c1cc(OC(F)(F)F)ccc1Cl
Relative Density.1.35 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 50 mg/mL (123.20 mM)
H2O: < 0.1 mg/mL (insoluble), Sonication and heating to 60℃ are recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.4640 mL12.3201 mL24.6403 mL123.2013 mL
5 mM0.4928 mL2.4640 mL4.9281 mL24.6403 mL
10 mM0.2464 mL1.2320 mL2.4640 mL12.3201 mL
20 mM0.1232 mL0.6160 mL1.2320 mL6.1601 mL
50 mM0.0493 mL0.2464 mL0.4928 mL2.4640 mL
100 mM0.0246 mL0.1232 mL0.2464 mL1.2320 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy GPR120 Agonist 3 | purchase GPR120 Agonist 3 | GPR120 Agonist 3 cost | order GPR120 Agonist 3 | GPR120 Agonist 3 chemical structure | GPR120 Agonist 3 in vivo | GPR120 Agonist 3 in vitro | GPR120 Agonist 3 formula | GPR120 Agonist 3 molecular weight